Changjiang Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 72% in 2022

Changjiang Pharmaceutical Group Co.,Ltd. (长江医药控股股份有限公司) (300391.SZ) reported a net profit of 44.6 million yuan in 2022, down 72% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, down 31.6% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 53.5%.